Topic
American Society of Clinical Oncology annual meeting
4 recent stories · updated continuously
The Independent
New Dual-Action Drug Shows Promise in Treating Advanced Lung Cancer
healthJust now
Theguardian
New Drug Daraxonrasib Doubles Survival Time for Pancreatic Cancer Patients
healthJust now
The Independent
New Drug Daraxonrasib Nearly Doubles Survival Time for Pancreatic Cancer Patients
healthJust now
Stat
Revolution Medicines' Daraxonrasib Shows Promising Results in Pancreatic Cancer Trials
healthJust now
